TITLE

Pharmas Pickier About Trial Sites

AUTHOR(S)
Sullivan, Laurie
PUB. DATE
September 2006
SOURCE
Pharma DD: Tracking Discovery & Development;Sep/Oct2006, Vol. 1 Issue 2, p14
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article highlights the findings of a benchmarking study conducted by KMR Group regarding the decision of pharmaceutical companies to carefully select a site for clinical trial in the U.S. Measures are being taken by the industry to enhance efficiencies in the clinical trial process according to David Spaight, president of MDS Pharma Services.
ACCESSION #
23475280

 

Related Articles

  • Tools for Clinical Trials Professionals.  // Applied Clinical Trials;Mar2006, Vol. 15 Issue 3, p28 

    No abstract available.

  • One World, One Voice. Delagneau, Bruno // Pharmaceutical Executive;Jul2004, Vol. 24 Issue 7, p76 

    Discusses the benefits to the pharmaceutical industry of the regulatory harmonization that started in the United States in the 1990s. Provision for companies to limit the length and expense of global clinical development programs by conducting large clinical studies at key centers worldwide;...

  • Clinical Trials in Serbia: From Strong to Stronger. Gallagher, Rory // Applied Clinical Trials;Apr2006, Vol. 15 Issue 4, p70 

    The article discusses the emergence of Serbia as one of the most popular destinations in the competitive market for clinical trials in 2006. Key issues discussed include an examination of the pharmaceutical industry of Serbia and the impact of the Serbian government's implementation of tax...

  • Arpida Gains On Iclaprim Data From Second cSSSI Pivotal Trial. Sheridan, Cormac // BioWorld International;7/18/2007, Vol. 12 Issue 29, p1 

    This article reports that Arpida AG is on track to file for marketing approval for its intravenous antibiotic iclaprim in the U.S. and Europe before the end of 2007. The company got positive topline data from a second pivotal trial of the drug in patient with complicated skin and skin structure...

  • Engaging Tomorrow's Volunteers Through Museum Learning. Getz, Kenneth A. // Applied Clinical Trials;Jun/Jul2014, Vol. 23 Issue 6/7, p18 

    The article discusses the efforts to provide outreach and education to inform patients and the public about the clinical research process. The author reveals that the National and international polls conducted by the Center for Information and Study on Clinical Research Participation (CISCRP)...

  • Caution When Traveling Full Speed Ahead. Kaylynn Chiarello-Ebner // Pharmaceutical Technology;Jan2007, Vol. 31 Issue 1, p16 

    The author reflects on the implications of accelerated drug trials among pharmaceutical companies. She focuses on the disadvantage of the process wherein due to the being on fast track there is less time to scale up and fine tune the product, which is a key factor in drug development. She also...

  • Clear Road Ahead. Grimes, Lisa // Pharmaceutical Executive;Oct2005, Vol. 25 Issue 10, p104 

    Focuses on the issues about clinical-trial registries in the U.S. Launching of clinical-trial registries and results databases by pharmaceutical companies and government agencies; Importance of registries in the patient's welfare and the needs of companies performing drug development; Increase...

  • India's drug tests. Padma, T. V. // Nature;7/28/2005, Vol. 436 Issue 7050, p485 

    Reports on the convergence of drug companies in India to conduct low-cost clinical trials. Details on the average cost of a clinical trial in the country; Problems of contract research organizations in recruiting participants for its trials; Accounts on the issue of ethics in conducting the tests.

  • POLL: Industry Should Focus on Drug Safety.  // Applied Clinical Trials;Oct2005, Vol. 14 Issue 10, p18 

    Reports on results of "Applied Clinical Trials" magazine's online poll about issues in which the pharmaceutical industry should focus on to regain public trust. Drug safety; Drug promotion; Global supply chain integrity; Regulatory climate; Open clinical trial registries.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics